Stoke Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Stoke Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Stoke Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Stoke Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $190k | 16k | 12.29 |
| 2024-06-30 | $206k | 15k | 13.51 |
| 2024-03-31 | $148k | 11k | 13.50 |
| 2023-12-31 | $95k | 18k | 5.26 |
| 2023-09-30 | $105k | 27k | 3.94 |
| 2023-06-30 | $246k | 23k | 10.63 |
| 2023-03-31 | $731k | 86k | 8.46 |
| 2022-12-31 | $220k | 24k | 9.20 |
| 2022-06-30 | $293k | 23k | 13.01 |
| 2022-03-31 | $411k | 20k | 20.98 |
| 2021-12-31 | $390k | 16k | 24.02 |
| 2021-03-31 | $373k | 9.6k | 38.87 |
| 2020-12-31 | $373k | 6.0k | 62.07 |
| 2020-09-30 | $156k | 4.6k | 34.26 |
| 2020-06-30 | $117k | 4.7k | 25.00 |
| 2020-03-31 | $212k | 5.5k | 38.46 |
| 2019-12-31 | $168k | 3.0k | 55.56 |
| 2019-09-30 | $64k | 3.0k | 21.33 |